EXpress Prevent Rural oldEr Adults' fallS, fractureS and Dependency (EXPRESS)
EXPRESS
AI-assisted, Village Doctors and Express Services-Involved, Community-Based Multicenter Cluster Randomized Controlled Trial for Fall Prevention Among Rural Older Adults
2 other identifiers
interventional
1,881
1 country
1
Brief Summary
Falls are the leading cause of injury-related death among individuals aged 65 and above in China. The incidence of falls shows a significant urban-rural disparity in China, with rural areas experiencing a markedly higher rate than urban regions. However, a systematic fall prevention strategy tailored to the needs of older people in rural China has not yet been established. The EXPRESS study is a multicenter, cluster-randomized controlled trial designed to explore the effectiveness and health economic evaluation of an AI-assisted, village doctors and express services-involved, personalized fall screening and prevention strategy based on multidimensional risk profiling in reducing the incidence of falls and fall-related injuries among older people in rural China. A total of 1,881 older individuals from 16 villages across four provinces in China (with four villages per province) will be recruited. These 16 rural areas will be randomly assigned to either the intervention group or the control group. The intervention group will receive the AI-assisted, village doctors and express services-involved personalized fall prevention strategy based on multidimensional fall risk screening and assessment, while the control group will follow routine primary health management practices. The intervention period will last for one year, with randomization taking place after the baseline survey. The primary outcomes are the incidence of falls and fall-related injuries (including falls resulting in hospitalization and fractures, etc). Secondary outcomes include activity of daily living, quality of life, fall-related health literacy, depressive symptoms, cognitive function, dementia, physical function and performance, incidence of chronic non-communicable diseases, frailty, and sleep quality.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started Aug 2024
Typical duration for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
August 6, 2024
CompletedFirst Submitted
Initial submission to the registry
May 11, 2025
CompletedFirst Posted
Study publicly available on registry
May 22, 2025
CompletedPrimary Completion
Last participant's last visit for primary outcome
August 30, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
August 30, 2026
ExpectedMay 22, 2025
May 1, 2025
1.1 years
May 11, 2025
May 18, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (3)
Fall incidence within 12 months (rate of falls per person-year)
Defined as the number of falls divided by total person-time of observation. To minimize recall bias in fall measurement, three methods will be employed: self-recording by older adults or their family members on a calendar, quarterly in-person inquiries by delivery personnel, and final evaluation through interviews conducted by an assessment officer.
Months 3, 6, 9, 12 after baseline survey
Proportion of participants with ≥1 fall within 12 months
A dichotomous outcome (fallers vs. non-fallers) that reflects risk reduction at the individual level. The measurement method is consistent with the fall incidence.
Months 3, 6, 9, 12 after baseline survey
Fall-related injuries incidence within 12 months
Fall-related injuries included fractures, head injuries, hospitalizations, other events requiring medical attention. The measurement method is consistent with the fall incidence.
Months 3, 6, 9, 12 after baseline survey
Secondary Outcomes (14)
Fall health literacy
Months 12 after baseline survey
Activities of daily living
Months 12 after baseline survey
Health-related Quality of life
Months 12 after baseline survey
Depressive symptoms
Months 12 after baseline survey
Cognitive function
Months 12 after baseline survey
- +9 more secondary outcomes
Study Arms (2)
AI-assisted, village doctors and express services-involved personalized fall prevention strategy
EXPERIMENTALEXPRESS intervention is structured around five key components-SAFER.
Control group
NO INTERVENTIONThe control group will receive standard health management through primary public health services and will be provided with a basic calendar to record fall events.
Interventions
The EXPRESS trial implements a pragmatic, community-based, AI-assisted fall prevention strategy tailored to the needs of older adults in rural China. The intervention is structured around five core components-SAFER: 1. Screening: multidimensional fall risk screening and assessment tailored to rural older adults; 2. AI-assisted recommendations: AI-assisted personalized fall prevention recommendations; 3. Fitness: Tailored balance and strength training via Health Intervention Cartoon Brochure and Action Demonstration Video; 4. Events-based engagement: culturally integrated seasonal intervention packages following the traditional Chinese calendar; 5. Reach-home delivery: home delivery of fall prevention services through local couriers.
Eligibility Criteria
You may qualify if:
- The village has a health clinic with at least one full-time village doctor.
- Village officials and village doctors are actively cooperative and willing to participate in the study.
- The village is located more than 2 kilometers away from other villages.
You may not qualify if:
- Administrative villages where the township government is located (due to potential bias from centralized use of medical resources).
- Villages that have previously conducted any form of fall-related knowledge promotion or intervention trials.
- Age 65 years or older.
- Resides in the village for at least 12 months.
- Provides informed consent and is willing to voluntarily participate.
- Suffering from major diseases such as cancer or stroke.
- Disability.
- Severe cognitive impairment.
- Severe visual or perceptual impairments.
- Any other condition preventing participation in the intervention.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
China Center for Health Development Studies, Peking University
Haidian, Beijing Municipality, China
Study Officials
- PRINCIPAL INVESTIGATOR
Yao Yao, MD
Peking University
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- TRIPLE
- Who Masked
- PARTICIPANT, CARE PROVIDER, OUTCOMES ASSESSOR
- Purpose
- PREVENTION
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Research professor
Study Record Dates
First Submitted
May 11, 2025
First Posted
May 22, 2025
Study Start
August 6, 2024
Primary Completion
August 30, 2025
Study Completion (Estimated)
August 30, 2026
Last Updated
May 22, 2025
Record last verified: 2025-05
Data Sharing
- IPD Sharing
- Will not share
Subject protection requirements